[Clinical aspects of the classification of anti-angina drugs].
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000787:Angina Pectoris / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D008996:Monoamine Oxidase Inhibitors / Q000627:therapeutic use*; D005996:Nitroglycerin / Q000627:therapeutic use; D011602:Psychophysiologic Disorders / Q000188:drug therapy; D013565:Sympatholytics / Q000627:therapeutic use*; D014149:Tranquilizing Agents / Q000627:therapeutic use*; D014665:Vasodilator Agents / Q000627:therapeutic use*
D000319:Adrenergic beta-Antagonists; D008996:Monoamine Oxidase Inhibitors; D013565:Sympatholytics; D014149:Tranquilizing Agents; D014665:Vasodilator Agents; D005996:Nitroglycerin
Aspects cliniques de la classification des médicaments antiangineux.